Global law firm Reed Smith announced today that it served as legal counsel to its long-time client Adagio Medical, a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, on its business combination with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company. Upon closing of the transaction, the combined company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ADGM".
The cross-office Reed Smith M&A team advising Adagio Medical was led by partners Michael Sanders, Jennifer W. Cheng, and Susan Nieto, based in Los Angeles, New York, and Philadelphia, respectively. Critical support for this transaction was provided by New York partner Michael S. Lee, Chicago partner Ben Brimeyer and Orange County partner Christopher Raidy, all in the firm’s corporate practice.
Original source can be found here.